Post Profile






Illumina’s Pain Infects Biotech ETFs

Biotech exchange-traded funds are in pain, yet again, with the iShares Nasdaq Biotechnology ETF (IBB) and the VanEck Vectors Biotech ETF (BBH) falling 2.5% and 2.3% respectively. This time, the blame falls on Illumina (ILMN). The gene sequencing company plunged more than 25% in morning market action after the company warned that third-quarter sales, due to be released on Nov.
read more

share

Related Posts


Do Low-Vol Funds Deliver On Their Promises?

Business & Finance / Investing : Focus on Funds

Smart beta ETFs have dominated new launches this year, and low-vol is one of the most popular categories, with BlackRock (BLK) calling its iShares MSCI USA Minimum Volatility Index Fund (USMV) the fastest domestic equity iShares ETF...

Biotech ETFs Punished For Owning Alnylam

Business & Finance / Investing : Focus on Funds

Bad news for Alnylam Pharmaceuticals (ALNY) appears to be taking a bite out of two big biotech ETFs. The iShares Nasdaq Biotechnology ETF (IBB) fell 2.3%, while the SPDR S&P Biotech ETF (XBI) shed 2.9% after Alnylam got destroyed to...

Last Week Saw More ETF Inflows And Mutual Fund Outflows

Business & Finance / Investing : Focus on Funds

Credit Suisse’s Victor Lin and his team take a look at weekly fund flows, which once again saw inflows for ETFs and outflows for mutual funds. U.S. listed exchange traded products attracted $6.8 billion last week, helped by the ongo...

Biotech Stocks Are Getting Crushed (SPX, SPY, DIA, DJI, QQQ, IBB)

Business & Finance : Business Insider: Clusterstock

U.S. stock indices are trading higher in the final session of the week — except for the Nasdaq, which is in the red. Notably, hot biotech stocks are selling off — the IBB, the iShares Nasdaq Biotechnology ETF, is down 3.7%. Other re...

Stocks Fall BioTech ETF still Up YTD

Business & Finance / Investing : The StockMasters

Despite Friday's fall BioTech is still up. After last week's major decline the Dow Jones is now negative for the year, the S&P 500 is only up 1%, but the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) is up 24% YTD. The covet...

Comments


Copyright © 2016 Regator, LLC